CoraLite®594 Anti-Human IL-2 Rabbit Recombinant Antibody

IL-2 Uni-rAbTM Recombinant Antibody for FC (Intra)
Cat No. CL594-98053

产品说明书

CloneNo. 240416E3

宿主/亚型

Rabbit / IgG

种属反应性

human

应用

FC (Intra)

IL2, 240416E3, IL 2, interleukin 2, Interleukin-2

缓冲液配方:  PBS and Azide
PBS and Azide
规格: 

-/ -


经过测试的应用

Positive FC (Intra) detected inPMA, Ionomycin and Brefeldin A treated human PBMCs
For other applications, we recommend the unconjugated version of this antibody, 98053-1-PBS

推荐稀释比

应用推荐稀释比
This reagent has been pre-titrated and tested for flow cytometric analysis. The suggested use of this reagent is 5 ul per 10^6 cells in a 100 µl suspension or 5 ul per 100 µl of whole blood.
Sample-dependent, Check data in validation data gallery.

产品信息

CL594-98053 targets IL-2 in FC (Intra) applications and shows reactivity with human samples.

经测试应用 FC (Intra) Application Description
经测试反应性 human
免疫原 IL-2 fusion protein Eg0828 种属同源性预测
宿主/亚型 Rabbit / IgG
抗体类别 Recombinant
产品类型 Antibody
全称 interleukin 2
别名 IL2, 240416E3, IL 2, interleukin 2, Interleukin-2
计算分子量 153 aa, 18 kDa
GenBank蛋白编号BC070338
基因名称 IL2
Gene ID (NCBI) 3558
偶联类型 CoraLite®594 Fluorescent Dye
最大激发/发射波长588 nm / 604 nm
形式 Liquid
纯化方式Protein A purification
UNIPROT IDP60568
储存缓冲液 PBS with 0.09% sodium azide and 0.5% BSA, pH 7.3.
储存条件Store at 2-8°C. Avoid exposure to light. Stable for one year after shipment.

背景介绍

Interleukin-2 (IL-2) is a four-helix bundle, type I cytokine that functions as a growth factor for a wide range of leukocytes. In the immune system, IL-2 is essential for immune homeostasis, normal T regulatory cell function, and self-tolerance. It regulates immune cell homeostasis and has been used to treat a range of disorders including cancer and autoimmune disease. IL-2 signals through heterodimerization of the IL-2Rβ and IL-2Rγ receptor subunits (PMID: 25992858, 24907378, 15034008, 17981641).

实验方案

Product Specific Protocols
FC protocol for CL594 IL-2 antibody CL594-98053Download protocol
Standard Protocols
Click here to view our Standard Protocols
Loading...